Breast Cancer Prescribing Guide
Apple Academic Press Inc.
1st Edition
Published on 12. February 2018
Book
Paperback/Softback
400 pages
978-1-4822-1500-7 (ISBN)
Description
An essential comprehensive reference, this book provides valuable guidance on prescribing commonly encountered clinical oncology situations. It includes a full literature review, clinical and expert contributions and NICE guidelines where appropriate, as well as a section on the complex issues involved when treating special patient groups. The text also covers therapy options and site-specific prescribing and contains a detailed section on pain and palliative management, including pharmacological and non-pharmacological approaches, such as neuromodulation and acupuncture therapy. It offers advice on pharmacovigilence and a touch on new drugs in development in clinical trials.
More details
Language
English
Place of publication
Oakville
Canada
Target group
College/higher education
Professional and scholarly
Professional Reference
Dimensions
Height: 229 mm
Width: 152 mm
ISBN-13
978-1-4822-1500-7 (9781482215007)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Content
Therapies - Introduction To Treatment Options, Chemotherapy, Targeted Therapies (Including Hormone Therapies), Radiotherapy, Vaccines, Therapies in Relation to Surgery, Complementary Therapies, Over the Counter Medications, Site Specific Prescribing, Breast, Gynaecological, Haematological, Lung, Skin, Head and Neck, Central Nervous System, Gastrointestinal, Genitourinary, Ophthalmic, Sarcoma, Unknown Primary Site, Pain & Palliative Management, Pharmacological, Non-Pharmacological, Special Patient Groups, The Paediatric Patient, The Adolescent / Young Adult, Fecundity Preservation, The Pregnant Patient, The Senior Patient, The Patient with Hepatic Impairment, The Patient with Renal Impairment, The Obese Patient, The Metastatic Patient, Prescribing Caution, Drug Reactions/Side Effects, Toxicity Management, Contra-Indications, Drug Interactions (Pharmacodynamic & Pharmacokinetic), Key Food Interactions, Drug Storage, Patient Adherence & Management, Pipeline and Emerging Therapies, Recently Launched/Approved Drugs, Key Phase III Drug Development Data, Key Phase II Drug Development Data.